SURF Surface Oncology
- 1.0700
- 0.00000.00%
Surface Oncology News
Surface Oncology | 4: Statement of changes in beneficial ownership of securities-Director Sigal Charles Elliott
Surface Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Adams Chandra
Surface Oncology | 4: Statement of changes in beneficial ownership of securities-Officer RATH HENRY C.
Surface Oncology | 4: Statement of changes in beneficial ownership of securities-Director Goater Jeff
Surface Oncology | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer FEES JESSICA
Surface Oncology | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer ROSS ROBERT W.
Surface Oncology | 4: Statement of changes in beneficial ownership of securities-Director GRAYZEL DAVID S.
Surface Oncology | 4: Statement of changes in beneficial ownership of securities-Officer ONEILL ALISON
Surface Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Adams Chandra
Surface Oncology | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer FEES JESSICA
Surface Oncology | 4: Statement of changes in beneficial ownership of securities-Officer ONEILL ALISON
Surface Oncology | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer ROSS ROBERT W.
Surface Oncology | SC 13G: Statement of acquisition of beneficial ownership by individuals-ADAR1 Partners, LP(5.24%),ADAR1 Capital Management, LLC(5.24%), etc.
Surface Oncology | 4: Statement of changes in beneficial ownership of securities-Officer RATH HENRY C.
Surface Oncology | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer ROSS ROBERT W.
Surface Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Adams Chandra
Surface Oncology | 4: Statement of changes in beneficial ownership of securities-Officer ONEILL ALISON
Surface Oncology | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer FEES JESSICA
Surface Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Palombella Vito J.
Surface Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(6.5%),Oleg Nodelman(6.5%), etc.
Analysis
Price Target
No Data
No Data